The global histology and cytology consumables market is anticipated to be worth USD 8,637.6 million in 2023. The market is expected to expand at a CAGR of 10.2% between 2023 and 2033.
Increased demand for the detection of cell and tissue features and an increase in the global occurrence of cell-based disorders such as cancer are projected to drive the market over the forecast period.
The market for histology and cytology consumables is expected to be worth around USD 22,833 million by the end of 2033. Historically, histology and cytology consumables consumption inclined at a 6.8% value CAGR.
| Report Attribute | Key Statistics |
|---|---|
| Expected Market Value (2023) | USD 8,637.6 million |
| Anticipated Forecast Value (2033) | USD 22,833 million |
| Projected Growth Rate (2023 to 2033) | 10.2% CAGR |
The use of digital technologies in cytological diagnosis provides the benefit of quick interpretation of basic diagnostic data. Furthermore, businesses are introducing new and advanced digital cytology equipment to aid in the speedy on-site screening of cytology samples.
Antech Diagnostics, for example, is expected to launch a digital cytology scanner in North America in June 2021. This scanner can offer whole-slide interpretations in less than 2 hours, which helps to save examination time and examine a large amount of samples in POC situations.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Increased demand for research and development for early disease detection and diagnosis, increased healthcare spending. An increase in hospitals and diagnostic laboratories, and increased demand for personalized medicines necessitates the study of individual cell structure and function, an increase in the prevalence of cell-based diseases such as cancer and autoimmune diseases requires the detection and diagnosis of specific cells and tissue.
Technological advancements in the diagnosis and treatment of infectious illnesses and molecular approaches may drive the need for histology and cytology consumables soon.
Despite continual advances in cytology and histology technology, they have at times been mainly inconclusive, leaving a void in the histology and cytology consumables industry. In biopsies, for example, histology and cytology are used. This factor is anticipated to hamper the worldwide histology and cytology consumables market.
Principal Consultant
| Countries | Market CAGR % (2023 to 2033) |
|---|---|
| China | 14.5% |
| India | 11.9% |
Prominent economic development has increased healthcare availability in the Asia Pacific region. The increase in multi-specialty clinics and hospitals, as well as the penetration of global players in Asia, is expected to fuel demand for histology and cytology consumables for research and development, as well as advancing the diagnostic and treatment process.
From 2023 to 2033, the Asia Pacific market for histology and cytology is predicted to grow at the quickest pace. The regional market is expanding as a result of numerous factors, including increased cancer awareness, a big target population, and improved healthcare infrastructure. Furthermore, researchers are progressively exploring novel cytology, boosting the region's market expansion.
For example, in February 2020, Japanese researchers compared the effectiveness of liquid-based cytology against traditional cytology in cervical cancer screening. From a practical sense, the study's findings revealed that liquid-based cytology was more beneficial than traditional cytology.
| Region | Europe |
|---|---|
| Market Share % (2022) | 28.1% |
According to Future Market Insights, Europe is expected to hold a more than 28.1% market share in the global histology and cytology consumables market as of 2023. As a result of the inherent character of industrialized healthcare infrastructure, the European markets embrace modern technology at an earlier stage than emerging countries, resulting in a rise in cancer incidence rate, which follows improved diagnostic methods in Europe.
| Region | North America |
|---|---|
| Market Share % (2022) | 40% |
In 2022, North America dominated the market with a revenue share of 40.0%. The high prevalence of cancer, substantial research and development efforts, the existence of important players, and the developed research infrastructure for pathology services all contribute to the regional market's growth. Furthermore, the region's high product approval and commercialization rate add to market expansion.
North America is expected to have a leading share. According to the World Health Organization, by 2030, there are expected to be around 23.6 million additional instances of cancer worldwide, boosting government spending on healthcare in the United States.
| Segment | Kits and Reagents |
|---|---|
| Market Share % (2022) | 55.2% |
In 2023, the kits and reagents category led the market, accounting for 55.2% of total revenue. From 2023 to 2033, the category is likely to retain its lead. Tissue sample containers, kits, stain reagents, fixative solutions, medium reagents, and other reagents are the consumables used in histology and cytology.
The segment's expansion can be traced mostly to the widespread use of histology and cytology consumables. Furthermore, firms are introducing low-cost kits and reagents, propelling the histology and cytology market.
For example, Biocide Medical LLC, in partnership with Ethyl Laboratories, introduced the TIGIT [BLR047F] antibody in August 2020, a novel rabbit monoclonal antibody for the qualitative detection of the TIGIT protein utilizing Immunohistochemistry (IHC). The antibody is expected to provide pharmaceutical and biotech research organizations with a low-cost Immunohistochemistry option.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The histology and cytology consumables landscape is witnessing significant activity regarding start-up ecosystems. Numerous life science companies are making inroads into the market, each bringing promising developments in the histology & cytology field. Some notable start-up players in this domain are as follows:
Consumables that enhance the specificity and sensitivity of histological and cytological tests are the goal of companies in the histology and cytology consumables industry.
Some businesses have increased their investments in the release of novel anatomical pathology consumables to suit the most demanding demands of contemporary histology laboratories. Numerous internationally important producers of cytology and histology apparatus and dyes have increased their holdings in the histology and cytology consumables supply industry.
Thermo Fisher Scientific, Inc., Danaher Corporation, Abbott Laboratories, Becton Dickinson and Company, F. Hoffmann-La Roche Ltd, Promega Corporation, Agilent Technologies Inc., Roche Holding AG, Merck KGaA, Allergan, Plc, PerkinElmer, Inc., and others are among the key players in the global histology and cytology consumables industry.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 10.2% from 2023 to 2033 |
| Market Value in 2023 | USD 8,637.6 million |
| Market Value in 2033 | USD 22,833.0 million |
| Base Year for Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in USD million and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
Product Type, Application, End User, Region |
| Regions Covered |
North America; Latin America; Europe; Asia Pacific; The Middle East and Africa |
| Key Countries Profiled | The United States, Canada, Brazil, Mexico, Germany, The United Kingdom, France, Spain, Italy, China, Japan, South Korea, Malaysia, Singapore, Australia, New Zealand, GCC Countries, South Africa, Israel |
| Key Companies Profiled |
Thermo Fisher Scientific, Inc.; Danaher Corporation; Abbott Laboratories; Becton Dickinson and Company; F. Hoffmann-La Roche Ltd; Promega Corporation; Agilent Technologies Inc.; Roche Holding AG; Merck KGaA; Allergan, Plc.; PerkinElmer, Inc. |
| Customization | Available Upon Request |
The market is valued at USD 8,637.6 million in 2023.
Merck KGaA, Allergan, Plc., PerkinElmer, Inc. are key market players.
By 2033, the market will reach USD 22,833 million.
The market’s CAGR from 2023 to 2033 will be 10.2%.
The China market’s expected CAGR over the forecast period is 14.5%.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Histology and Cytology Kits and Reagents 5.2. Histology and Cytology Enzymes 5.3. Histology and Cytology Stains and Dyes 5.4. Other Histology and Cytology Consumable Products 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 6.1. for Molecular Diagnostic Study 6.2. for Cell Signaling 6.3. for Clinical Diagnosis 6.4. for Epigenetics and Sequencing Study 6.5. for Other Applications 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 7.1. Histology and Cytology and Consumables for Hospitals 7.2. Histology and Cytology and Consumables for Diagnostic Centers 7.3. Histology and Cytology and Consumables for Biotechnology and Pharmaceutical Industry 7.4. Histology and Cytology and Consumables for Academic Research Institutes 7.5. Histology and Cytology and Consumables for Other End Users 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. North America 8.2. Latin America 8.3. Western Europe 8.4. Eastern Europe 8.5. South Asia and Pacific 8.6. East Asia 8.7. Middle East and Africa 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16. Key Countries Market Analysis 17. Market Structure Analysis 18. Competition Analysis 18.1. Thermo Fisher Scientific, Inc. 18.2. Danaher Corporation 18.3. Abbott Laboratories 18.4. Becton Dickinson and Company 18.5. F. Hoffmann-La Roche Ltd 18.6. Promega Corporation 18.7. Agilent Technologies Inc. 18.8. Roche Holding AG 18.9. Merck KGaA 18.10. Allergan, Plc. 18.11. PerkinElmer, Inc. 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Histology and Cytology Consumables Market
